Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

399 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Management of ulcerative colitis and Crohn's disease.
Baert F, Vermeire S, Noman M, Van Assche G, D'Haens G, Rutgeerts P. Baert F, et al. Among authors: van assche g. Acta Clin Belg. 2004 Sep-Oct;59(5):304-14. doi: 10.1179/acb.2004.045. Acta Clin Belg. 2004. PMID: 15641402 Review.
Demographic and clinical parameters influencing the short-term outcome of anti-tumor necrosis factor (infliximab) treatment in Crohn's disease.
Vermeire S, Louis E, Carbonez A, Van Assche G, Noman M, Belaiche J, De Vos M, Van Gossum A, Pescatore P, Fiasse R, Pelckmans P, Reynaert H, D'Haens G, Rutgeerts P; Belgian Group of Infliximab Expanded Access Program in Crohn's Disease. Vermeire S, et al. Among authors: van assche g, van gossum a. Am J Gastroenterol. 2002 Sep;97(9):2357-63. doi: 10.1111/j.1572-0241.2002.05991.x. Am J Gastroenterol. 2002. PMID: 12358256 Free article.
The role of aminosalicylates in the treatment of ulcerative colitis.
Van Assche G, Baert F, De Reuck M, De Vos M, De Wit O, Hoang P, Louis E, Mana F, Pelckmans P, Rutgeerts P, Van Gossum A, D'Haens G. Van Assche G, et al. Among authors: van gossum a. Acta Gastroenterol Belg. 2002 Oct-Dec;65(4):196-9. Acta Gastroenterol Belg. 2002. PMID: 12619425
C-reactive protein as a marker for inflammatory bowel disease.
Vermeire S, Van Assche G, Rutgeerts P. Vermeire S, et al. Among authors: van assche g. Inflamm Bowel Dis. 2004 Sep;10(5):661-5. doi: 10.1097/00054725-200409000-00026. Inflamm Bowel Dis. 2004. PMID: 15472532 Review.
Predictors of early response to infliximab in patients with ulcerative colitis.
Ferrante M, Vermeire S, Katsanos KH, Noman M, Van Assche G, Schnitzler F, Arijs I, De Hertogh G, Hoffman I, Geboes JK, Rutgeerts P. Ferrante M, et al. Among authors: van assche g. Inflamm Bowel Dis. 2007 Feb;13(2):123-8. doi: 10.1002/ibd.20054. Inflamm Bowel Dis. 2007. PMID: 17206703 Clinical Trial.
399 results